Cochlear implants (CIs) became life-transforming devices for children with severe hearing loss. Initially, CIs were contraindicated for children with inner ear malformations (IEMs), who constitute approximately 20%-35% of the congenital sensorineural hearing loss cases. 1-3 Cochlear structures can be evaluated by computed tomography (CT) and magnetic resonance imaging (MRI). Most children with IEMs have bilateral severe to profound hearing loss and are candidates for a CI or an auditory brainstem implant (ABI). 4-6 The IEMs' classification system includes eight groups 4 : Complete Labyrinthine Aplasia (Michel Deformity), Rudimentary Otocyst, Cochlear Aplasia (CA), Common Cavity (CC), Cochlear Hypoplasia (CH), Incomplete Partition of the Cochlea I-II-III (IP-I, IP-II, IP-III), Enlarged Vestibular Aqueduct (EVA), and Cochlear Aperture Abnormalities (CAA). The IEMs' incidence at our clinic is 11.5%, 2 but at present, they comprise 21% of children undergoing CI surgery.